NCT02714855View on ClinicalTrials.gov

Apixaban in the Prevention of Stroke and Systemic Embolism in Patients With Atrial Fibrillation in Real-Life Setting in France

CompletedOBSERVATIONAL
Enrollment

2,081

Participants

Timeline

Start Date

October 31, 2015

Primary Completion Date

December 31, 2016

Study Completion Date

December 31, 2016

Conditions
Anticoagulation
Interventions
DRUG

Apixaban

Trial Locations (1)

21121

Local Institution, Fontaine-lès-Dijon

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY